OncoTargetTM provides oncologists with clinically-actionable data including:
• A complete list of all identifiable mutations
• Relevant FDA-approved drugs
• Current clinical trials specific to your patient's cancer
Our OncoTargetTM - 88 Analysis Includes:
• Sequence analysis for 76 well-characterized cancer genes
• Copy number analysis for 13 well-characterized cancer genes
• Rearrangement analysis for 14 well-characterized cancer genes
• Microsatellite instability analysis for 5 markers
Insurance and Payment:
We accept all commercial insurances. If insurance does not cover OncoTargetTM testing, we offer a financial assistance program including discounted pricing and payment plans.
To learn more about OncoTargetTM download our complete OncoTarget brochure or contact us at 855.GOPATH9.